Bereich
Brustzentrum St.Gallen
BZ · Dept. IV
Gene expression profiling in breast cancer – design of a pooled database to address open questions
Knauer M. Gene expression profiling in breast cancer – design of a pooled database to address open questions. Eur Surg 2009; 41:221-227.
01.01.2009Gene expression profiling in breast cancer – design of a pooled database to address open questions
01.01.2009Eur Surg 2009; 41:221-227
Knauer Michael
Bevacizumab-associated osteonecrosis of the jaw
Greuter S, Schmid F, Ruhstaller T, Thürlimann B. Bevacizumab-associated osteonecrosis of the jaw. Ann Oncol 2008; 19:2091-2.
01.12.2008Bevacizumab-associated osteonecrosis of the jaw
01.12.2008Ann Oncol 2008; 19:2091-2
Greuter S, Schmid F, Ruhstaller Thomas, Thürlimann Beat
Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
Knauer M, Wenzl E, Offner F, Säly C, Jasarevic Z, Alton R, Winder T, Lang A, Köberle-Wührer R, Schneider Y, Haid A, deVries A. Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer. Eur J Surg Oncol 2008; 35:798-804.
14.11.2008Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
14.11.2008Eur J Surg Oncol 2008; 35:798-804
Knauer Michael, Wenzl E, Offner F A, Säly C, Jasarevic Z, Alton R, Winder T, Lang A, Köberle-Wührer R, Schneider Y, Haid A, deVries A
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Viale G, Olszewski W, Knox F, Thürlimann B, Price K, Castiglione-Gertsch M, Gelber R, Gusterson B, Goldhirsch A, Orosz Z, Neven P, Öhlschlegel C, Giobbie-Hurder A, Regan M, Coates A, Mastropasqua M, Dell'Orto P, Maiorano E, MacGrogan G, Braye S, Breast International Group Trial 1-98. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol 2008; 26:5569-75.
03.11.2008Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
03.11.2008J Clin Oncol 2008; 26:5569-75
Viale Giuseppe, Olszewski Wojciech P, Knox Fiona, Thürlimann Beat, Price Karen N, Castiglione-Gertsch Monica, Gelber Richard D, Gusterson Barry A, Goldhirsch Aron, Orosz Zsolt, Neven Patrick, Öhlschlegel Christian, Giobbie-Hurder Anita, Regan Meredith M, Coates Alan S, Mastropasqua Mauro G, Dell'Orto Patrizia, Maiorano Eugenio, MacGrogan Gaëtan, Braye Stephen G, Breast International Group Trial 1-98
Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
Grimm B, Padberg B, Ruhstaller T, Fleisch F, von Moos R. Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy. Onkologie 2008; 31:620-2.
01.11.2008Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
01.11.2008Onkologie 2008; 31:620-2
Grimm Birgit, Padberg Barbara, Ruhstaller Thomas, Fleisch Felix, von Moos Roger
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research
Koeberle D, Herrmann R, Mora O, Ruhstaller T, Strasser F, Beretta K, Mingrone W, Caspar C, Dietrich D, Gerber D, Borner M, Saletti P, Swiss Group for Clinical Cancer Research. Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3702-8.
01.08.2008Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research
01.08.2008Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3702-8
Koeberle Dieter, Herrmann Richard, Mora Oreste, Ruhstaller Thomas, Strasser Florian, Beretta Kurt, Mingrone Walter, Caspar Clemens B, Dietrich Daniel, Gerber Daniela, Borner Markus, Saletti Piercarlo, Swiss Group for Clinical Cancer Research
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001
Bernhard J, Pestalozzi B, Köhne C, Mingrone W, Stemmer S, Tàmas K, Kornek G, Koeberle D, Herrmann R, Figer A, Bauer J, Saletti P, Dietrich D, Scheithauer W, Gerber D, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Central European Cooperative Oncology Group. Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3695-701.
01.08.2008Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001
01.08.2008Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008; 26:3695-701
Bernhard Jürg, Pestalozzi Bernhard C, Köhne Claus-Henning, Mingrone Walter, Stemmer Salomon M, Tàmas Karin, Kornek Gabriela V, Koeberle Dieter, Herrmann Richard, Figer Arie, Bauer Jean, Saletti Piercarlo, Dietrich Daniel, Scheithauer Werner, Gerber Daniela, Bodoky György, Ruhstaller Thomas, Glimelius Bengt, Bajetta Emilio, Schüller Johannes, Central European Cooperative Oncology Group
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
Gruber G, Gusterson B, Viale G, Goldhirsch A, Price K, Coates A, Gelber R, Fey M, Simoncini E, Thürlimann B, Crivellari D, Collins J, Golouh R, Lindtner J, Holmberg S, Castiglione-Gertsch M, Cole B, International Breast Cancer Study Group. Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol 2008; 19:1393-401.
01.08.2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
01.08.2008Ann Oncol 2008; 19:1393-401
Gruber G, Gusterson B A, Viale G, Goldhirsch A, Price K N, Coates A S, Gelber R D, Fey M F, Simoncini E, Thürlimann Beat, Crivellari D, Collins J, Golouh R, Lindtner J, Holmberg S B, Castiglione-Gertsch M, Cole B F, International Breast Cancer Study Group
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Borner M, Mingrone W, Lanz D, Dietrich D, Kappeler A, Roth A, Ruhstaller T, Caspar C, Pestalozzi B, Helbling D, Trojan A, Hess V, Rauch D, Saletti P, von Moos R, Koeberle D, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:1288-92.
01.07.2008Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
01.07.2008Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008; 19:1288-92
Borner M, Mingrone W, Lanz D, Dietrich D, Kappeler A, Roth A, Ruhstaller Thomas, Caspar C, Pestalozzi B, Helbling D, Trojan A, Hess V, Rauch D, Saletti P, von Moos R, Koeberle D, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
von Moos R, Caspar C, Thürlimann B, Angst R, Inauen R, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M. Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study. Ann Oncol 2008; 19:1266-70.
01.07.2008Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
01.07.2008Ann Oncol 2008; 19:1266-70
von Moos R, Caspar C B, Thürlimann Beat, Angst Rahel, Inauen Roman, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Regan M, SOFT/TEXT/PERCHE Steering Committee, Gelber R, Goldhirsch A, Coates A, Castiglione-Gertsch M, Maibach R, Thürlimann B, Price K, Fleming G, Francis P, Perez E, Torrisi R, Walley B, Pagani O, International Breast Cancer Study Group. Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?. Ann Oncol 2008; 19:1231-41.
01.07.2008Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
01.07.2008Ann Oncol 2008; 19:1231-41
Regan M M, SOFT/TEXT/PERCHE Steering Committee, Gelber R D, Goldhirsch A, Coates A S, Castiglione-Gertsch M, Maibach R, Thürlimann Beat, Price K N, Fleming G F, Francis P, Perez E A, Torrisi R, Walley B, Pagani O, International Breast Cancer Study Group
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials
Pestalozzi B, Goldhirsch A, Coates A, Castiglione-Gertsch M, Viale G, Murray E, Thürlimann B, Snyder R, Lindtner J, Holmberg S, Gelber R, Price K, Gusterson B, Mallon E, Zahrieh D, International Breast Cancer Study Group. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. JCO 2008; 26:3006-14.
20.06.2008Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials
20.06.2008JCO 2008; 26:3006-14
Pestalozzi Bernhard C, Goldhirsch Aron, Coates Alan S, Castiglione-Gertsch Monica, Viale Giuseppe, Murray Elizabeth, Thürlimann Beat, Snyder Raymond, Lindtner Jurij, Holmberg Stig B, Gelber Richard D, Price Karen N, Gusterson Barry A, Mallon Elizabeth, Zahrieh David, International Breast Cancer Study Group
Dose-Dense Therapy
Untch M, Bergh J, Citron M, Hudis C, Huober J, Möbus V, Steger G. Dose-Dense Therapy. Breast Care (Basel) 2008; 3:134-138.
28.04.2008Dose-Dense Therapy
28.04.2008Breast Care (Basel) 2008; 3:134-138
Untch Michael, Bergh Jonas, Citron Mark, Hudis Clifford A, Huober Jens, Möbus Volker, Steger Günter
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial
Crivellari D, Chirgwin J, Smith I, Rabaglio M, Gladieff L, Del Mastro L, Láng I, Colleoni M, Gelber R, Castiglione-Gertsch M, Paridaens R, Forbes J, Mauriac L, Mouridsen H, Thürlimann B, Price K, Coates A, Sun Z, Goldhirsch A. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. JCO 2008; 26:1972-9.
20.04.2008Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial
20.04.2008JCO 2008; 26:1972-9
Crivellari Diana, Chirgwin Jacquie H, Smith Ian E, Rabaglio Manuela, Gladieff Laurence, Del Mastro Lucia, Láng István, Colleoni Marco, Gelber Richard D, Castiglione-Gertsch Monica, Paridaens Robert J, Forbes John F, Mauriac Louis, Mouridsen Henning, Thürlimann Beat, Price Karen N, Coates Alan S, Sun Zhuoxin, Goldhirsch Aron
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
von Minckwitz G, Kaufmann M, Mehta K, Loibl S, Jackisch C, Costa S, Huober J, Gerber B, Hilfrich J, Eidtmann H, Hanusch C, Vogel P, Kümmel S, German Breast Group. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. Journal of the National Cancer Institute 2008; 100:542-51.
16.04.2008Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
16.04.2008Journal of the National Cancer Institute 2008; 100:542-51
von Minckwitz Gunter, Kaufmann Manfred, Mehta Keyur, Loibl Sibylle, Jackisch Christian, Costa Serban Dan, Huober Jens, Gerber Bernd, Hilfrich Jörn, Eidtmann Holger, Hanusch Claus, Vogel Petra, Kümmel Sherko, German Breast Group
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
von Minckwitz G, Kaufmann M, Mehta K, Loibl S, Jackisch C, Costa S, Huober J, Gerber B, Hilfrich J, Eidtmann H, Hanusch C, Vogel P, Kümmel S, German Breast Group. Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study. Journal of the National Cancer Institute 2008; 100:552-62.
16.04.2008Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
16.04.2008Journal of the National Cancer Institute 2008; 100:552-62
von Minckwitz Gunter, Kaufmann Manfred, Mehta Keyur, Loibl Sibylle, Jackisch Christian, Costa Serban Dan, Huober Jens, Gerber Bernd, Hilfrich Jörn, Eidtmann Holger, Hanusch Claus, Vogel Petra, Kümmel Sherko, German Breast Group
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
Köberle D, Rust C, Bieri G, Neuweiler J, Terraciano L, Ruhstaller T, Heitzmann F, Hess V, Winterhalder R, von Moos R, Burkhard R, Toepfer M. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer 2008; 98:1204-9.
08.04.2008Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
08.04.2008British journal of cancer 2008; 98:1204-9
Köberle Dieter, Rust C, Bieri G, Neuweiler Jörg, Terraciano L, Ruhstaller Thomas, Heitzmann F, Hess V, Winterhalder R, von Moos R, Burkhard R, Toepfer M
[New treatment approaches in breast cancer]
Spirig C, Thürlimann B, Huober J. [New treatment approaches in breast cancer]. Therapeutische Umschau. Revue thérapeutique 2008; 65:207-10.
01.04.2008[New treatment approaches in breast cancer]
01.04.2008Therapeutische Umschau. Revue thérapeutique 2008; 65:207-10
Spirig Christian, Thürlimann Beat, Huober Jens
[Adjuvant endocrine therapy in breast cancer]
Huober J, Thürlimann B. [Adjuvant endocrine therapy in breast cancer]. Therapeutische Umschau. Revue thérapeutique 2008; 65:193-200.
01.04.2008[Adjuvant endocrine therapy in breast cancer]
01.04.2008Therapeutische Umschau. Revue thérapeutique 2008; 65:193-200
Huober Jens, Thürlimann Beat
Inappropriate ATAC on tamoxifen
Coates A, Mouridsen H, Thürlimann B, BIG 1-98 Collaborative Group. Inappropriate ATAC on tamoxifen. The Lancet 2008; 9:315-6.
01.04.2008Inappropriate ATAC on tamoxifen
01.04.2008The Lancet 2008; 9:315-6
Coates Alan, Mouridsen Henning, Thürlimann Beat, BIG 1-98 Collaborative Group